Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
Int J Oncol
    July 2022
  1. HAM IH, Wang L, Lee D, Woo J, et al
    Curcumin inhibits the cancerassociated fibroblastderived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.
    Int J Oncol. 2022;61.
    >> Share

    June 2022
  2. SAKATA K, Kanda M, Shimizu D, Nakamura S, et al
    Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer.
    Int J Oncol. 2022;60.
    >> Share

    May 2022
  3. ZHU H, Jiang W, Zhu H, Hu J, et al
    Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
    Int J Oncol. 2022;60.
    >> Share

    March 2022
  4. ZHU X, Liu J, Xu X, Zhang C, et al
    [Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.
    Int J Oncol. 2022;60.
    >> Share

    December 2021
  5. ITO K, Kitajima Y, Kai K, Matsufuji S, et al
    Matrix metalloproteinase1 expression is regulated by HIF1dependent and epigenetic mechanisms and serves a tumorsuppressive role in gastric cancer progression.
    Int J Oncol. 2021;59.
    >> Share

    April 2021
  6. OUYANG J, Xie Z, Lei X, Tang G, et al
    Clinical crosstalk between microRNAs and gastric cancer (Review).
    Int J Oncol. 2021;58:1.
    >> Share

    January 2021
  7. BALI P, Lozano-Pope I, Pachow C, Obonyo M, et al
    Early detection of tumor cells in bone marrow and peripheral blood in a fastprogressing gastric cancer model.
    Int J Oncol. 2021 Jan 12. doi: 10.3892/ijo.2021.5171.
    >> Share

    September 2020
  8. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    >> Share

  9. SUN Z, Gao X, Zabkiewicz C, Ruge F, et al
    Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
    Int J Oncol. 2020;57:813-824.
    >> Share

    May 2020
  10. XU X, Xia Y, Ma J, Li W, et al
    Upregulation of miRNA301a3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NFkappaB signaling.
    Int J Oncol. 2020 May 26. doi: 10.3892/ijo.2020.5072.
    >> Share

    April 2020
  11. LIU AG, Zhong JC, Chen G, He RQ, et al
    Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
    Int J Oncol. 2020 Apr 15. doi: 10.3892/ijo.2020.5048.
    >> Share

  12. YAMAKOSHI Y, Tanaka H, Sakimura C, Deguchi S, et al
    Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Int J Oncol. 2020 Apr 8. doi: 10.3892/ijo.2020.5042.
    >> Share

    February 2020
  13. LONG B, Qin L, Zhang B, Li Q, et al
    CAR Tcell therapy for gastric cancer: Potential and perspective (Review).
    Int J Oncol. 2020 Feb 12. doi: 10.3892/ijo.2020.4982.
    >> Share

    December 2019
  14. SUN T, Wang D, Ping Y, Sang Y, et al
    Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Int J Oncol. 2019 Dec 16. doi: 10.3892/ijo.2019.4944.
    >> Share

    November 2019
  15. SZATANEK R, Weglarczyk K, Stec M, Baran J, et al
    Autologous tumorderived microvesicles influence gene expression profiles and enhance protumorigenic chemotactic potential, signal transduction and cellular respiration in gastric cancer cells.
    Int J Oncol. 2019 Nov 26. doi: 10.3892/ijo.2019.4923.
    >> Share

    September 2019
  16. LI H, Wang C, Wei Z, Chen W, et al
    Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
    Int J Oncol. 2019 Sep 26. doi: 10.3892/ijo.2019.4885.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016